HAEMATO AG Share Price

Equities

HAEK

DE000A289VV1

Pharmaceuticals

End-of-day quote Hanseatische Wertpapierboerse Hamburg 03:30:00 02/07/2024 am IST 5-day change 1st Jan Change
16.7 EUR -1.18% Intraday chart for HAEMATO AG -4.57% 0.00%
1 week-4.57%
Current month-1.76%

Financials

Sales 2023 * 27Cr 29Cr 2.42TCr Sales 2024 * 28Cr 30Cr 2.53TCr Capitalization 8.99Cr 9.7Cr 810.02Cr
Net income 2023 * 70L 75.52L 63Cr Net income 2024 * 1Cr 1.08Cr 90Cr EV / Sales 2023 * 0.26 x
Net cash position 2023 * 2.12Cr 2.29Cr 191.03Cr Net cash position 2024 * 2.42Cr 2.61Cr 218.05Cr EV / Sales 2024 * 0.23 x
P/E ratio 2023 *
-
P/E ratio 2024 *
-
Employees 76
Yield 2023 *
-
Yield 2024 *
-
Free-Float 99.67%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.18%
1 week-4.57%
Current month-1.76%
1 month-8.74%
3 months+3.41%
More quotes
1 week
16.70
Extreme 16.7
17.30
1 month
16.50
Extreme 16.5
18.70
Current year
15.00
Extreme 15
20.80
1 year
15.00
Extreme 15
20.80
3 years
15.00
Extreme 15
20.80
5 years
15.00
Extreme 15
20.80
10 years
15.00
Extreme 15
20.80
More quotes
Date Price Change Volume
03/24/03 17.2 +2.99% 757
02/24/02 16.7 -1.18% 775
01/24/01 16.9 -0.59% 1,754
28/24/28 17 +0.29% 571
27/24/27 16.95 -1.74% 138

End-of-day quote Hanseatische Wertpapierboerse Hamburg, July 02, 2024

More quotes
Haemato AG, previously Windsor AG, is a Germany-based pharmaceutical company. The Company trades and patent-free and patent-protected medicines and generic drugs with focus on oncology, human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS), neurology, rheumatology, urology, cardiovascular diseases and other chronic diseases. The Company's main markets are Europe, North America and Japan. It also imports medicines from within the European Economic Area in form of parallel imports and re-imports. The Company's subsidiaries are Haemato Pharm GmbH, Heamato Med GmbH, Castell Pharma BV, Sanate GmbH and Heamato Asia Co Ltd. Customers can order medicine through phone, fax and e-mail, among others.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Quarterly revenue - Rate of surprise